title: Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.
abstract: Mutations in the CLN3 gene cause a fatal neurodegenerative disorder: juvenile CLN3 disease, also known as juvenile Batten disease. The two most commonly utilized mouse models of juvenile CLN3 disease are Cln3-knockout (Cln3(-/-)) and Cln3(Δex7/8)-knock-in mice, the latter mimicking the most frequent disease-causing human mutation. To determine which mouse model has the most pronounced neurological phenotypes that can be used as outcome measures for therapeutic studies, we compared the exploratory activity, motor function and depressive-like behavior of 1-, 3- and 6-month-old Cln3(-/-) and Cln3(Δex7/8)-knock-in mice on two different genetic backgrounds (129S6/SvEv and C57BL/6J). Although, in many cases, the behavior of Cln3(-/-) and Cln3(Δex7/8) mice was similar, we found genetic-background-, gender- and age-dependent differences between the two mouse models. We also observed large differences in the behavior of the 129S6/SvEv and C57BL/6J wild-type strains, which highlights the strong influence that genetic background can have on phenotype. Based on our results, Cln3(-/-) male mice on the 129S6/SvEv genetic background are the most appropriate candidates for therapeutic studies. They exhibit motor deficits at 1 and 6 months of age in the vertical pole test, and they were the only mice to show impaired motor coordination in the rotarod test at both 3 and 6 months. Cln3(-/-) males on the C57BL/6J background and Cln3(Δex7/8) males on the 129S6/SvEv background also provide good outcome measures for therapeutic interventions. Cln3(-/-) (C57BL/6J) males had serious difficulties in climbing down (at 1 and 6 months) and turning downward on (at 1, 3 and 6 months) the vertical pole, whereas Cln3(Δex7/8) (129S6/SvEv) males climbed down the vertical pole drastically slower than wild-type males at 3 and 6 months of age. Our study demonstrates the importance of testing mouse models on different genetic backgrounds and comparing males and females in order to find the most appropriate disease model for therapeutic studies.
authors.affiliation: Sanford Children's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA.
authors.forename: Attila D
authors.initials: AD
authors.lastname: Kovács
authors.affiliation: Sanford Children's Health Research Center, Sanford Research, Sioux Falls, SD 57104, USA. Department of Pediatrics, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 57104, USA. David.Pearce@sanfordhealth.org.
authors.forename: David A
authors.initials: DA
authors.lastname: Pearce
mesh_terms: D000375:Aging / Q000235:genetics / Q000473:pathology; D000818:Animals; D001835:Body Weight; D003863:Depression / Q000235:genetics / Q000473:pathology; D004195:Disease Models, Animal; D005106:Exploratory Behavior; D005260:Female; D055879:Gene Knock-In Techniques; D000068617:Genetic Background; D007103:Immobilization; D008297:Male; D008562:Membrane Glycoproteins / Q000172:deficiency / Q000378:metabolism; D008810:Mice, Inbred C57BL; D018832:Molecular Chaperones / Q000378:metabolism; D009043:Motor Activity; D009472:Neuronal Ceroid-Lipofuscinoses / Q000235:genetics* / Q000628:therapy*; D010641:Phenotype; D045442:Rotarod Performance Test; D012727:Sex Characteristics; D013997:Time Factors
chemical_list: C102229:CLN3 protein, mouse; D008562:Membrane Glycoproteins; D018832:Molecular Chaperones
keywords: 129S6/SvEv; Batten disease; C57BL/6J; CLN3; Cln3Δex7/8-knock-in mouse model; Cln3−/− mouse model; Juvenile neuronal ceroid lipofuscinosis